Form D · Pharmaceuticals

FOG PHARMACEUTICALS, INC.

Cambridge, MA · CIK 0001657677

Offering snapshot reported Dec 2, 2022 · SEC filing

Reported sold
$178M
Offering amount: $178M
Investors reported
24
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 17, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 2, 2022Initial$177,999,922No comparison24SEC filing
Jan 5, 2021Initial$23,271,035No comparison22SEC filing
May 16, 2018Amendment$65,514,944$30,500,001vs Feb 14, 201824SEC filing
Feb 14, 2018Initial$35,014,943No comparison17SEC filing
Aug 22, 2017Amendment$11,000,007$3,574,092vs Jun 7, 201613SEC filing
Jun 7, 2016Initial$7,425,915No comparison11SEC filing
Nov 13, 2015Initial$625,000No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-466472

Source: Form D, filed Dec 2, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Aceti Executive
Leon Chen Director
Edward M. Fitzgerald Director
Corey S. Goodman Director
Rick Klausner Director
Jeffrey A. Leerink Director
Gregory L. Verdine Director, Executive
Barbara Weber Director
Krishna Yeshwant Director
Wei Qing Zhou Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
30 Acorn Park Drive 6 Th Floor
Cambridge, MA, 02140